I'm going to roll the dice with long time disappointment GNBT. Upcoming call in a week on its promising cancer vaccine that looks grat in PII so far. Also, finally Shreya expected Oralyn to get approved this month in India. I don't think a multibagger is a stretch here ....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.